Literature DB >> 25687480

Obscure etiology, unusual disparity: the epidemiology of testicular cancer in New Zealand.

Jason K Gurney1, Diana Sarfati, James Stanley.   

Abstract

PURPOSE: Testicular cancer (TC) remains perplexing, both in terms of what causes the disease and why certain populations are at greater risk of developing it. In New Zealand, an unusual ethnic disparity exists, whereby the indigenous Māori population suffer the highest rates of disease. In this study, we further describe the epidemiology of TC in the New Zealand context.
METHODS: Eligible patients diagnosed with TC between 2000 and 2011 (n = 1,800) were determined from the NZ Cancer Registry and linked to mortality data. Census data were used to estimate population incidence of TC and tumor sub-type by ethnic group. Kaplan-Meier and Cox regression analyses were used to compare survival between ethnic groups.
RESULTS: Māori males aged 15-44 were 80% more likely to be diagnosed with TC compared to European/Other males [age-standardized relative risk (RR) 1.80, 95% CI 1.58-2.05]. By contrast, disease burden was comparatively low among Pacific and Asian populations. Māori had a greater incidence of both seminoma (RR 1.88, 95% CI 1.52-2.22) and non-seminoma (RR 1.67, 95% CI 1.35-2.07) germ cell tumors than the European/Other population, reducing the likelihood that our observed disparity is driven by differential propensity to one given sub-type among Māori. Māori had poorer survival outcomes [cancer-specific adjusted hazard ratio (HR) 2.29, 95% CI 1.14-4.59] than the European/Other population.
CONCLUSIONS: Understanding the drivers of New Zealand's unusual incidence disparities--particularly between Māori and Pacific--could further our understanding of the key exposures involved in TC etiology.

Entities:  

Mesh:

Year:  2015        PMID: 25687480     DOI: 10.1007/s10552-015-0533-4

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  4 in total

Review 1.  Risk factors for cryptorchidism.

Authors:  Jason K Gurney; Katherine A McGlynn; James Stanley; Tony Merriman; Virginia Signal; Caroline Shaw; Richard Edwards; Lorenzo Richiardi; John Hutson; Diana Sarfati
Journal:  Nat Rev Urol       Date:  2017-06-27       Impact factor: 14.432

2.  Testicular Germ-Cell Tumours: A Descriptive Analysis of Clinical Characteristics at First Presentation.

Authors:  Klaus-Peter Dieckmann; Hanna Richter-Simonsen; Magdalena Kulejewski; Raphael Ikogho; Henrik Zecha; Petra Anheuser; Uwe Pichlmeier; Hendrik Isbarn
Journal:  Urol Int       Date:  2018-04-12       Impact factor: 2.089

3.  International Trends in the Incidence of Testicular Cancer: Lessons from 35 Years and 41 Countries.

Authors:  Jason K Gurney; Andrea A Florio; Ariana Znaor; Jacques Ferlay; Mathieu Laversanne; Diana Sarfati; Freddie Bray; Katherine A McGlynn
Journal:  Eur Urol       Date:  2019-07-17       Impact factor: 20.096

4.  Testicular Cancer in New Zealand (TCNZ) study: protocol for a national case-control study.

Authors:  Jason K Gurney; James Stanley; Katherine McGlynn; Lorenzo Richiardi; Caroline Shaw; Richard Edwards; Tony R Merriman; Bridget Robson; Jonathan Koea; Melissa McLeod; Martin A Kennedy; Diana Sarfati
Journal:  BMJ Open       Date:  2018-08-05       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.